Archives

by in
Entry Author Date Location
MSU Bioeconomy Institute Snags State and Federal Funding For Proof of Concept Center 11/29/11 Detroit
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring 11/22/11 San Diego
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
The Stroke Prevention War is On: FDA Approves J&J/Bayer Contender 11/07/11 New York
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Sanford-Burnham Joins Fold at Pfizer’s Centers for Therapeutic Innovation 11/03/11 San Diego
Biopharma Industry Meetings Could Use Some Fresh Voices 11/01/11 Seattle
The Cancer Drug Dark Ages Are Coming to an End 10/31/11 National
Illumina Leads $8M Investment in GenoLogics to Help Manage DNA Data Overload 10/20/11 Seattle
NextBio Sees Growth in Next Market: Physicians Seeking Help Interpreting Individual Genomes 10/18/11 San Francisco
Computers vs. Humans: A Recap of Xconomy’s New York Life Sciences 2031 10/14/11 New York
Join Xconomy Tonight for New York Life Sciences 2031 10/13/11 New York
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News 10/13/11 Seattle
Pfizer, deCode Genetics Strike Deal To Look For New Lupus Drug Targets 10/12/11 New York
A Preview of Xconomy Forum: New York Life Sciences 2031 10/11/11 New York
Stem Cell Therapy: A Process With a Promise 10/10/11 Seattle
Smoke on the Water: Fireworks at the Cleveland Clinic Medical Innovation Summit 10/10/11 San Francisco
Blueprint Health, New Incubator in NYC, Looks to Nurture Health IT Startups 10/03/11 New York
Why Universities Are Key to the Future of Biotech, and How UCSF’s Chief is Showing the Way 10/03/11 National
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News 09/30/11 Boston
Xconomist of the Week: Pfizer’s Barbara Dalton to Speak at Our NY Life Sciences 2031 Forum 09/29/11 New York
Ambrx Grabs $24M Upfront in New Diabetes, Heart Failure Research Deal With Bristol-Myers 09/22/11 San Diego
Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C 09/22/11 Seattle
Merck Joins the Big Pharma VC Party, Setting Up $250M Biotech Investment Fund 09/15/11 National
Latest in Stroke-Prevention Saga: FDA Panel Backs Drug From J&J and Bayer 09/09/11 New York
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Bristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and Bayer 09/08/11 New York
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News 09/08/11 Seattle
PTC Acquires 4CS, Goby Picked Up by TeleNav, Punchbowl Nabs Funding, & More Boston-Area Deals News 09/07/11 Boston
Sam Waksal, Pfizer Venture Investments, and More: Moderator Looks Forward to All-Star Chat at New York Life Sciences 2031 09/06/11 New York
Page 2 of 14 « previous page · next page »
    

Xconomy Events Across the Network

XSITE 2012: The Xconomy Summit on Innovation, Technology & Entrepreneurship

Boston · 6/14/12
8:30 am - 5:00 pm

More Xconomy Events

Xconomy’s Most Popular

  1. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  2. Biotech IPOs Start to Show Some Modest Signs of Life
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
  5. Announcing Xconomy’s Napa Summit: Keeping America Growing

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.